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OBJECTIVES In the present study, we evaluated sinus and atrioventricular (AV) node electrophysiology of
endurance athletes and untrained individuals before and after autonomic pharmacologic
blockade.
BACKGROUND Endurance athletes present a higher prevalence of sinus bradycardia and AV conduction
abnormalities, as compared with untrained individuals. Previous data from our laboratory
suggest that nonautonomic factors may be responsible for the longer AV node refractory
period found in well-trained athletes.
METHODS Six aerobically trained male athletes and six healthy male individuals with similar ages and
normal rest electrocardiograms were studied. Maximal oxygen uptake (V˙O2max) was
measured by cardiopulmonary testing. The sinus cycle length (SCL), AV conduction
intervals, sinus node recovery time (SNRT), Wenckebach cycle (WC) and anterograde
effective refractory period (ERP) of the AV node were evaluated by invasive electrophysi-
ologic studies at baseline, after intravenous atropine (0.04 mg/kg) and after addition of
intravenous propranolol (0.2 mg/kg).
RESULTS Athletes had a significantly higher V˙O2max as compared with untrained individuals. The
SCL was longer in athletes at baseline, after atropine and after the addition of propranolol for
double-autonomic blockade. The mean maximal SNRT/SCL was longer in athletes after
atropine and after propranolol. The WC and anterograde ERP of the AV node were longer
in athletes at baseline, after atropine and after propranolol.
CONCLUSIONS Under double-pharmacologic blockade, we demonstrated that sinus automaticity and AV
node conduction changes of endurance athletes are related to intrinsic physiology and not to
autonomic influences. (J Am Coll Cardiol 2002;39:1033–8) © 2002 by the American
College of Cardiology Foundation
The electrocardiogram (ECG) of endurance athletes reflects
anatomic and physiologic adaptations that have been
brought about by training (1,2). Sinus bradycardia and
atrioventricular (AV) conduction abnormalities represent
part of the spectrum of arrhythmias seen on the ECG of
athletes, and most studies have attributed these findings to
a relative or absolute increase in parasympathetic activity
(1,2). However, the precise mechanism of these training-
induced arrhythmias is still uncertain. We have recently
used transesophageal atrial stimulation to evaluate aerobi-
cally trained athletes and sedentary individuals, to test the
hypothesis that parasympathetic activity, as detected by
heart rate variability, could be associated with changes in
AV conduction (3). Athletes presented with Wenckebach
AV node conduction at rates lower than those of sedentary
individuals, suggesting a longer AV node refractory period.
However, this could only be partially explained by increased
parasympathetic activity, as detected by a time domain index
of heart rate variability, suggesting that nonautonomic
factors could contribute to this change in AV conduction. In
the present study, we used pharmacologic blockade of the
autonomic nervous system during intracavitary electrophysi-
ologic studies to evaluate sinus node automaticity and AV
node conduction in aerobically trained athletes and un-
trained individuals, to test the hypothesis that the altered
sinus and AV electrophysiology of athletes is related to
intrinsic and not autonomic adaptations.
METHODS
Study subjects and protocol. Six male runners who ran at
least 50 km per week and six healthy but nonathletic men
who had not participated in regular aerobic activity for at
least one year were studied. During the experiments, the
subjects did not ingest any food or beverage containing
caffeine, and they were taking no medications. None of the
participants exercised in the 24 h before the procedures. A
medical history, physical examination, rest ECG and max-
imal exercise test were obtained to exclude pathologic
conditions. For each subject, maximal oxygen uptake
(V˙O2max) was measured by a treadmill test, and sinus
automaticity and AV node conduction were evaluated by
intracavitary electrical stimulation at baseline and after
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pharmacologic blockade. All subjects were informed of the
risks and discomforts involved in the experiments and gave
written, informed consent. In light of the results of our
previous experiments (3), as well as the risks involved with
the performance of invasive electrophysiologic studies in
asymptomatic individuals (4), our institution’s Research
Committee approved the protocol for six athletes and six
untrained individuals. The protocol was also approved by
the Brazilian National Council for Research (CONEP,
Brasilia, Brazil).
Measurement of V˙O2max. The subjects exercised on a
motor-driven treadmill (Inbramed TK 10,200, Porto
Alegre, Brazil); the 12-lead ECG was continuously moni-
tored; and respiratory gases were analyzed by using a
previously validated commercial system (Total Energy Ex-
penditure Measurements, Aerosport, Ann Harbor, Michi-
gan) (5). For the athletes, the exercise protocol started at a
speed of 4 km/h, with additional increments of 2 km/h
every 2 min until volitional fatigue. For untrained individ-
uals, the protocol was started at a speed of 2 km/h, with
additional increments of 2 km/h every 2 min until volitional
fatigue.
Electrophysiologic study and pharmacologic blockade.
The electrophysiologic study was performed with the sub-
jects in the postabsorptive state. The subjects rested in the
supine position for 15 min, and a 12-lead surface ECG was
recorded on a Funbec (Sa˜o Paulo, Brazil) electrocardio-
graph. The PR interval and corrected QT (QTc  QT ·
[RR]1) interval were measured. Correction of the QT
interval was used to control for the different rest heart rates
of the groups. The subjects were then continuously moni-
tored by pulse oximetry and electrocardiography. A cannula
was inserted in the antecubital vein, and 2 mg of midazolam
was initially administered intravenously. Additional doses of
midazolam were given throughout the procedure, if neces-
sary for sedation. After local anesthesia of the right groin
with 1% lidocaine, two sheaths were introduced percutane-
ously into the right femoral vein. Under fluoroscopic guid-
ance (calculated radiation exposure of 28 to 42 mGy), two
7F, deflectable, multipolar electrode catheters were posi-
tioned against the high right atrial wall, near the region of
the sinus node, and across the tricuspid valve in the area of
the His bundle for recordings of intracardiac electrograms
and pacing. Baseline intracardiac conduction intervals were
then measured during sinus rhythm (6). Electrical stimula-
tion of the atrium was performed with a programmable
stimulator (UHS 20, Biotronik, Germany) using 2-ms,
constant-current pulses at approximately twice the late
diastolic threshold. Surface ECG leads and bipolar intra-
cardiac electrograms filtered at a bandpass of 30 to 500 Hz
were displayed and recorded simultaneously on a multichan-
nel recorder (Mingograf 7, Siemens, Germany) at a paper
speed of 50 or 100 mm/s.
After control recordings, the atrium was paced for 30-s
periods, at constant cycle lengths of 600, 500 and 400 ms,
and the rhythm was monitored to ensure complete atrial
capture. At least 30 s was allowed to elapse between each
successive pacing period. Measurements of sinus node
recovery time (SNRT) were made using bipolar electro-
grams recorded from the proximal two poles of the high
atrial catheter; SNRT was defined as the time from the last
paced stimulus to the onset of the first deflection on the
electrogram of the first sinus beat. To control for differences
in sinus rate, SNRT was normalized for the spontaneous
sinus cycle length (SCL) (7). At least five consecutive cycles
following each pacing period and after the rhythm had
returned to the control cycle length were used to calculate
the mean SCL. In each individual, the longest (maximal)
SNRT was determined. The Wenckebach cycle (WC) of
the AV node was defined as the cycle length during
incremental atrial pacing where the AV node Wenckebach
phenomenon was noted. The anterograde effective refrac-
tory period (ERP) of the AV node was measured using
an eight-beat drive at a cycle length equal to the SCL 
100 ms, followed by a single premature atrial stimulus
introduced decrementally at 10-ms intervals. The antero-
grade ERP of the AV node was defined as the longest
coupled premature atrial stimuli interval that failed to
propagate to the His bundle (6).
Parasympathetic blockade was induced by administration
of atropine, 0.04 mg/kg body weight intravenously (8,9).
After a stable sinus rate had been achieved, the electrophysi-
ologic variables described earlier were again measured.
Double-autonomic blockade was then obtained by addition
of 0.2 mg/kg of propranolol intravenously, and, after SCL
stabilization, a final set of electrophysiologic variables was
obtained again (8,9). Sheaths were pulled out; hemostasis
was obtained by pressure; and the subjects rested in a
recovery room for 6 h.
Statistical analyses. Data are presented as the mean SD.
Differences between athletes and nonathletes were com-
pared by using the Student t test. The effects of pharmaco-
logic blockade on the electrophysiologic variables were
compared by two-way analysis of variance (ANOVA) for
repeated measures. When appropriate, multiple compari-
sons were made by the Student Newman-Keuls method.
Based on the results of our previous study using transesoph-
ageal stimulation (3), and assuming a lower variability of the
data due to sedation, we estimated that a sample size of six
individuals in each group would have a statistical power of
Abbreviations and Acronyms
ANOVA  analysis of variance
AV  atrioventricular
ECG  electrocardiogram
ERP  effective refractory period
SCL  sinus cycle length
SNRT  sinus node recovery time
V˙O2max  maximal oxygen uptake
WC  Wenckebach cycle
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80% to detect a 20% difference in the electrophysiologic
variables, at p  0.05.
RESULTS
Table 1 describes the demographic, rest ECG and exercise
testing data for athletes and untrained individuals. The
groups were similar in terms of age, weight and height. In
athletes, the rest heart rate was significantly lower and
V˙O2max was significantly higher. The rest ECG intervals
were similar in the two groups and within the normal range
for all subjects.
The mean AV conduction intervals and atrial P-wave,
atrial His-bundle and ventricular His-bundle values were
similar, within the normal range, and responded typically
and alike during the pharmacologic interventions in athletes
and nonathletes (Table 2). The mean SCLs in athletes and
nonathletes were 1,030  111 and 913  90 ms, 737  59
and 653  43 ms and 831  71 and 722  43 ms at
baseline, after parasympathetic blockade and after double-
autonomic blockade, respectively (ANOVA: p  0.01 for
group effect; p  0.01 for drug effect; p  0.365 for
interaction). Atropine increased and propranolol decreased
the heart rate (p  0.05) in similar proportions in both
groups—that is, the SCL of the athletes always remained
longer than the SCL of the nonathletes (Fig. 1). The mean
maximal SNRT/SCL ratios in athletes and nonathletes
were 1.56  0.16 and 1.5  0.09, 1.36  0.19 and 1.26 
0.06 and 1.45  0.09 and 1.31  0.05 at baseline, after
parasympathetic blockade and after double-autonomic
blockade, respectively (ANOVA: p  0.01 for group effect;
p  0.01 for drug effect; p  0.640 for interaction). As
expected, atropine decreased and propranolol increased (p
0.05) the mean maximal SNRT/SCL ratio, but, unexpect-
edly, the recovery time of the athletes was significantly
longer than that of the nonathletes after both parasympa-
thetic and double-autonomic blockade, despite being ex-
pressed as a ratio of SCL (Fig. 1). The mean length of the
WC of the AV node in athletes and nonathletes was 575 
73 and 453 51 ms, 423 46 and 342 25 ms and 493
56 and 413  28 ms at baseline, after parasympathetic
blockade and after double-autonomic blockade, respectively
(ANOVA: p  0.01 for group effect; p  0.01 for drug
effect; p  0.370 for interaction) (Fig. 1). The mean
anterograde ERP of the AV node in athletes and nonath-
letes was 425  46 and 313  44 ms, 338  47 and 257 
26 ms and 408  53 and 282  43 ms at baseline, after
parasympathetic blockade and after double-autonomic
blockade, respectively (ANOVA: p  0.01 for group effect;
p  0.01 for drug effect; p  0.690 for interaction) (Fig. 1).
As with SCL, the WC and anterograde ERP were reduced
by atropine and increased by propranolol, but the values for
athletes remained significantly longer than those for non-
athletes.
DISCUSSION
The rest ECGs of the well-trained endurance athlete may
show certain distinguished features that are similar, in many
respects, to those seen in patients with cardiovascular
disease. Among the most frequent rhythm changes are sinus
bradycardia and AV conduction abnormalities. Rest sinus
bradycardia may be found in the great majority of endurance
athletes, and borderline or first-degree AV block may be
observed in 10% to 33% and second-degree Wenckebach
block in 2% to 10% of long-distance runners (10). These
abnormalities have been related to higher parasympathetic
activity owing to their association with training and detrain-
ing, as well as their disappearance after sympathetic or
vagolytic maneuvers (11).
Because of the invasive nature of electrophysiologic stud-
ies, there is little information on atrial automaticity and AV
node conduction of healthy athletes. Mezzani et al. (12)
performed invasive electrophysiologic studies in a group of
athletes and a group of untrained individuals, all with
Wolff-Parkinson-White syndrome. In that study, athletes
showed a longer SCL, atrial effective and functional refrac-
tory periods and anterograde ERP of the accessory pathway;
these findings were attributed to autonomic influences. In
our previous study of endurance-trained athletes and un-
trained individuals evaluated by transesophageal stimula-
Table 2. Electrophysiologic Intervals at Baseline, After Atropine
and After Propranolol
P-A
Interval (ms)
H-A
Interval (ms)
H-V
Interval (ms)
Baseline
Athletes 34  9 94  25 46  6
Untrained 32  4 93  17 43  6
Atropine
Athletes 38  9 76  22* 45  6
Untrained 33  4 80  15* 44  6
Propranolol
Athletes 36  9 92  23 46  6
Untrained 32  4 89  15 42  8
Data are presented as the mean value  SD.
*Significantly different from baseline value, with no significant interaction.
H-A  atrial His bundle; H-V  ventricular His bundle; P-A  atrial P wave.
Table 1. Physical Characteristics and Rest Electrocardiographic
and Maximal Exercise Test Results of Athletes and
Untrained Subjects
Athletes
(n  6)
Untrained
(n  6) p Value
Age (years) 29  4 28  5 NS
Weight (kg) 78  1 77  2 NS
Height (cm) 178  8 178  9 NS
Rest heart rate (beats/min) 52  8 73  7 0.001
PR interval (ms) 168  15 156  16 NS
Corrected QT interval (ms) 412  9 398  5 NS
Maximal heart rate (beats/min) 188  11 191  13 NS
Maximal respiratory exchange
ratio
1.18  0.8 1.16  0.7 NS
V˙O2max (ml/kg per min) 65  1 38  4 0.001
Data are presented as the mean value  SD.
NS  not significant; V˙O2max  maximal oxygen uptake.
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tion, only 24% of the variance in WC could be accounted
for by the vagal time domain index of heart rate variability—
the square root of the mean of the sum of squares of
differences between adjacent RR intervals (3). Thus, we
proposed that athletic training could induce intrinsic adap-
tations in the conduction system, which would contribute to
the higher prevalence of AV conduction abnormalities in
athletes. On the basis of these intriguing observations, the
Research Committee of our institution approved a new
protocol with pharmacologic blockade and invasive electro-
physiology data acquisition. Using a cross-sectional design,
in the present study we evaluated two distinct groups, in
which athletes had lower rest heart rate and higher directly
measured V˙O2max when compared to nonathletes. We
chose to use intracavitary electrophysiologic measurements
under sedation to reduce the influence of psychological
stress. Under these controlled conditions, we found evi-
dence that sinus automaticity and AV node conduction of
athletes at rest are determined by intrinsic electrophysi-
ologic adaptations, rather than by autonomic influences.
Sinus automaticity in athletes. Some investigators who
also used pharmacologic blockade have attributed training-
induced sinus bradycardia to an imbalance of the two
branches of the autonomic nervous system—that is, in-
creased parasympathetic activity, decreased sympathetic ac-
tivity or a combination of these (13). In contrast, other
studies using pharmacologic blockade have proposed that
alterations in the intrinsic properties of the sinus node, the
so-called “nonautonomic component,” were responsible for
rest bradycardia of athletes (14,15). Likewise, some studies
that used heart rate variability methods, which may detect
vagal adaptations (16), demonstrated an increase in para-
sympathetic activity (17,18), although others were not able
to demonstrate this effect (3,19). The effects of autonomic
blockade on the SCL of our endurance athletes are consis-
tent with the concept that long-term, training-induced rest
sinus bradycardia is not caused by increased parasympathetic
activity or decreased sympathetic activity, but is related to
intrinsic adaptations. Indeed, atropine and propranolol caused
parallel shifts in the sinus automaticity of athletes and nonath-
letes—that is, the incremental and decremental changes were
identical. Increased parasympathetic activity would cause
greater heart rate responses post-atropine and a reduction in
sympathetic activity would cause lesser heart rate responses
post-propranolol in athletes than in nonathletes.
The maximal SNRT/SCL of athletes was significantly
longer than that of nonathletes after both parasympathetic
and double-autonomic blockade, compatible with nonauto-
nomic adaptation. This longer recovery time may reflect
greater overdrive suppression, longer retrograde and antero-
grade sinoatrial conduction times or both. In view of the
effects on AV node conduction, it is tempting to speculate
about the substantial impact of these sinoatrial conductive
components.
Atrioventricular node conduction in athletes. In the
present study, the effects of autonomic blockade on the WC
and anterograde ERP of the AV node were equal to the
effects on SCL. The differences in these electrophysiologic
measurements between athletes and untrained individuals
were very similar in magnitude at baseline, after atropine
and after propranolol, again discordant with the view of an
imbalance in autonomic activity. These findings are consis-
tent with the experiments conducted by Yamaya et al. (20),
who used pharmacologic blockade in horses with AV node
conduction abnormalities. Similar to the findings in horses,
our data indicate that prolonged and intensive training did
not disrupt the normal balance of the autonomic nervous
system, and that the longer SCL and refractory period of the
AV node were essentially caused by significant intrinsic
electrophysiologic modifications. These findings also con-
firmed our previous observations (3) suggesting that the
longer AV node refractory period of athletes could be
Figure 1. The sinus cycle length (SCL), maximal normalized sinus node recovery time (SNRT)/SCL ratio and Wenckebach cycle (WC) and anterograde
(Ant) effective refractory period (ERP) of the atrioventricular node at baseline, after atropine and after propranolol in endurance-trained athletes (solid
circles) and untrained individuals (solid squares). Data are presented as the mean value  SD. *Significant (p  0.05) differences between athletes and
untrained individuals. †Significantly different (p  0.05) from previous pharmacologic intervention.
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mediated mainly by nonautonomic factors, most likely
induced by athletic training.
Possible mechanisms. The physiologic mechanisms by
which endurance training may induce these intrinsic
changes in the specialized conduction system of the heart
are unknown and may be multifactorial. An altered ionic
balance across the membrane (21), as well as biochemical
and mechanical effects induced by dilation and hypertrophy
(14,15), have been proposed as possible mechanisms. Clin-
ical and research data indicate that active and passive
changes in the mechanical environment of the heart are
capable of influencing both the initiation and spread of
cardiac excitation through pathways that are intrinsic to the
heart—a phenomenon known as “mechanoelectric feed-
back” (22). One unifying explanation for the controversy
about autonomic versus nonautonomic determinants of
electrophysiologic adaptations in athletes could be that
short-term physical training programs, such as those used in
prospective studies (13,18), could induce autonomic adap-
tations, with a reduction in sympathetic activity and an
increase in parasympathetic activity. Long-term aerobic
training, accompanied by anatomic changes such as atrial
and ventricular dilation, would create the mechanoelectric
feedback necessary to induce intrinsic electrophysiologic
adaptations, as demonstrated in the present and other
cross-sectional studies (3,14,15). Interestingly, rats (23) and
dogs (24) whose hearts were denervated before training did
not develop intrinsic and rest bradycardia, respectively.
Thus, it is likely that a functioning autonomic system is
necessary for the development of electrophysiologic adapta-
tions.
Possible clinical relevance. In the present study, we eval-
uated a group of well-trained athletes with rest bradycardia,
but without conduction abnormalities. Thus, the demon-
stration of intrinsic electrophysiologic adaptations can be
generalized only to other athletes with similar characteris-
tics. However, taken together with our previous observa-
tions in another group of endurance athletes (3), we believe
that intrinsic adaptations represent the electrophysiologic
substrate that may facilitate the appearance of more ad-
vanced conduction abnormalities. The demonstration by
Zepilli et al. (11) of a reversal in conduction abnormalities of
athletes by sympathetic or vagolytic maneuvers may simply
represent normal parasympathetic activity superimposed on
altered intrinsic electrophysiology.
Study limitations. In this study, we assumed that the
differences between athletes and untrained individuals rep-
resent physiologic adaptations in response to training. Be-
cause this is a cross-sectional study, an alternative explana-
tion could be that the intrinsic changes represent inherited
characteristics that may facilitate success or trainability.
However, this is unlikely, based on the observations of
previous prospective studies on sinus bradycardia (13,18)
and conduction abnormalities of athletes (11). The use of
pharmacologic blockade as a tool for the evaluation of
autonomic and nonautonomic influences on electrophysi-
ologic variables also has its limitations. The possible sym-
pathomimetic effect of atropine (25), as well as its attenu-
ated antagonism (26), could have confounded our findings.
However, both of these actions, if anything, would have
resulted in overestimation of parasympathetic activity, par-
ticularly in favor of the athletes (9), which we did not find
in our study.
Conclusions. Our controlled intracavitary electrophysi-
ologic studies under pharmacologic blockade demonstrate
that endurance athletes with rest bradycardia and a normal
ECG present with sinus automaticity and AV node con-
duction changes that are related to intrinsic physiology,
rather than to autonomic influences.
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